Insider Trades
News
globenewswire.comJupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Diseaseglobenewswire.comMay 27
accessnewswire.comD. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offeringaccessnewswire.comMay 26
globenewswire.comJupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offeringglobenewswire.comMay 21
globenewswire.comJupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offeringglobenewswire.comMay 20
benzinga.comJupiter Stock Soars After $100 Million ALA-002 Licensing Dealbenzinga.comMay 20